Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models
Titel:
Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models
Auteur:
Gozgit, Joseph M. Squillace, Rachel M. Wongchenko, Matthew J. Miller, David Wardwell, Scott Mohemmad, Qurish Narasimhan, Narayana I. Wang, Frank Clackson, Tim Rivera, Victor M.